A carregar...
Brivaracetam: review of its pharmacology and potential use as adjunctive therapy in patients with partial onset seizures
Brivaracetam (BRV), a high-affinity synaptic vesicle protein 2A ligand, reported to be 10–30-fold more potent than levetiracetam (LEV), is highly effective in a wide range of experimental models of focal and generalized seizures. BRV and LEV similarly bind to synaptic vesicle protein 2A, while diffe...
Na minha lista:
Publicado no: | Drug Des Devel Ther |
---|---|
Main Authors: | , , , , , , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Dove Medical Press
2015
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4622453/ https://ncbi.nlm.nih.gov/pubmed/26543353 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S81474 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|